Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer (Fierce Biotech)
Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer (Fierce Biotech)